Li Minghui, Cao Weihua, Xie Yao
Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
HBV Infection, Clinical Cure and Immunology Joint Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
China CDC Wkly. 2025 Jul 25;7(30):987-990. doi: 10.46234/ccdcw2025.167.
The year 2025 marks the 15th anniversary of World Hepatitis Day, a milestone that has witnessed remarkable progress in global viral hepatitis prevention and treatment. This article systematically examines the establishment and evolution of World Hepatitis Day, emphasizing the latest achievements in hepatitis control through 2025. Current data demonstrate that global hepatitis B vaccine coverage has surpassed the 90% target, while a cumulative 12,748,000 hepatitis C patients received direct-acting antivirals (DAAs) treatment from 2014 to 2023. Despite these advances, persistent challenges, including suboptimal diagnosis rates and pronounced regional disparities continue to impede progress toward the 2030 elimination objectives. Drawing from the most recent epidemiological data, this article presents targeted recommendations to accelerate global elimination efforts.
2025年是世界肝炎日15周年，这一里程碑见证了全球病毒性肝炎预防和治疗取得的显著进展。本文系统回顾了世界肝炎日的设立与发展，重点介绍了截至2025年肝炎防控的最新成果。当前数据显示，全球乙肝疫苗接种覆盖率已超过90%的目标，2014年至2023年期间，累计有1274.8万丙肝患者接受了直接抗病毒药物（DAA）治疗。尽管取得了这些进展，但持续存在的挑战，包括诊断率不理想和明显的地区差异，继续阻碍着实现2030年消除目标的进程。本文根据最新的流行病学数据，提出了有针对性的建议，以加速全球消除工作。
